Remote Programming of Cochlear Implants.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 12 2 2019
pubmed: 12 2 2019
medline: 26 2 2020
Statut: ppublish

Résumé

This study investigated the safety and efficacy of remote programming of cochlear implants. Single-subject design SETTING:: Four North American clinical sites PATIENTS:: Forty cochlear implant recipients aged 12 years or older INTERVENTION:: Subjects had their cochlear implants programmed at a location that was remote from their audiologist using telecommunication with and without the support of a facilitator. Consonant-Nucleus-Consonant (CNC) word scores and the Speech, Spatial, and Qualities of Hearing Scale-C (SSQ-C) were compared using the subject's in-office MAP (program) and MAPs programmed remotely with and without the assistance of a facilitator. Additional subjective preference data were gathered from subjects and audiologists via questionnaires. MAPs programmed via the three different models did not yield significantly different group mean CNC word scores. No device/procedure-related adverse events occurred. SSQ-C questionnaire results indicated that recipients received similar subjective benefit from familiar in-office, remote-facilitated, and remote-unassisted MAPs. Remote programming is an effective means of cochlear implant service delivery. The practice was approved by the FDA on November 17, 2017 supported by the results of this study.

Identifiants

pubmed: 30741905
doi: 10.1097/MAO.0000000000002119
pii: 00129492-201903000-00037
pmc: PMC6380526
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e260-e266

Références

Telemed J E Health. 2008 Dec;14(10):1101-17
pubmed: 19119834
Psychol Sci. 2000 Mar;11(2):153-8
pubmed: 11273423
Cochlear Implants Int. 2010 Jun;11 Suppl 1:461-4
pubmed: 21756673
J Speech Lang Hear Res. 2017 Mar 1;60(3):732-740
pubmed: 28257529
J Speech Hear Res. 1978 Sep;21(3):507-18
pubmed: 713519
Int J Audiol. 2004 Feb;43(2):85-99
pubmed: 15035561
J Telemed Telecare. 2014 Mar 27;20(4):171-177
pubmed: 24675003
J Speech Lang Hear Res. 2012 Aug;55(4):1112-27
pubmed: 22232388
Health Aff (Millwood). 2014 Feb;33(2):258-64
pubmed: 24493769
Otol Neurotol. 2005 Mar;26(2):188-95
pubmed: 15793403
J Speech Hear Disord. 1962 Feb;27:62-70
pubmed: 14485785
Codas. 2014 Nov-Dec;26(6):481-6
pubmed: 25590911
Acta Otolaryngol. 2014 Jul;134(7):709-16
pubmed: 24773208
Otol Neurotol. 2010 Sep;31(7):1035-40
pubmed: 20147864
Acta Otolaryngol. 2010 Dec;130(12):1379-88
pubmed: 20586675
Telemed J E Health. 2013 Jul;19(7):557-64
pubmed: 23705961
Acta Otolaryngol. 2009 May;129(5):533-40
pubmed: 18649152
Cochlear Implants Int. 2010 Jun;11 Suppl 1:489-92
pubmed: 21756680
J Acoust Soc Am. 1997 Jul;102(1):508-22
pubmed: 9228814

Auteurs

Heidi K Slager (HK)

Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan.

Jamie Jensen (J)

Medical College of Wisconsin, Koss Cochlear Implant Program, Milwaukee, Wisconsin.

Kristin Kozlowski (K)

Medical College of Wisconsin, Koss Cochlear Implant Program, Milwaukee, Wisconsin.

Holly Teagle (H)

Department of Otolaryngology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Lisa R Park (LR)

Department of Otolaryngology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Allison Biever (A)

Rocky Mountain Ear Center PC, Englewood.

Megan Mears (M)

Cochlear Americas, Centennial, Colorado.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH